| Sample | Title | Value | Rank |
|---|
| GSM780707 | Untreated after 4 days (C1_1) | 147.735 | 80 |
| GSM780708 | Untreated after 4 days (C2_1) | 190.1 | 83 |
| GSM780709 | Untreated after 4 days (C3_1) | 172.524 | 82 |
| GSM780719 | Untreated after 4 days (C1_2) | 144.209 | 80 |
| GSM780720 | Untreated after 4 days (C2_2) | 215.811 | 84 |
| GSM780721 | Untreated after 4 days (C3_2) | 196.138 | 83 |
| GSM780710 | Trastuzumab treated after 4 days (T1_1) | 181.813 | 83 |
| GSM780711 | Trastuzumab treated after 4 days (T2_1) | 193.403 | 83 |
| GSM780712 | Trastuzumab treated after 4 days (T3_1) | 176.436 | 82 |
| GSM780722 | Trastuzumab treated after 4 days (T1_2) | 219.685 | 85 |
| GSM780723 | Trastuzumab treated after 4 days (T2_2) | 190.507 | 83 |
| GSM780724 | Trastuzumab treated after 4 days (T3_2) | 178.586 | 82 |
| GSM780713 | Pertuzumab treated after 4 days (P1_1) | 166.239 | 82 |
| GSM780714 | Pertuzumab treated after 4 days (P2_1) | 178.342 | 82 |
| GSM780715 | Pertuzumab treated after 4 days (P3_1) | 192.399 | 83 |
| GSM780725 | Pertuzumab treated after 4 days (P1_2) | 183.734 | 83 |
| GSM780726 | Pertuzumab treated after 4 days (P2_2) | 183.924 | 83 |
| GSM780727 | Pertuzumab treated after 4 days (P3_2) | 173.136 | 82 |
| GSM780716 | Trastuzumab and Pertuzumab treated after 4 days (TP1_1) | 226.039 | 85 |
| GSM780717 | Trastuzumab and Pertuzumab treated after 4 days (TP2_1) | 198.798 | 83 |
| GSM780718 | Trastuzumab and Pertuzumab treated after 4 days (TP3_1) | 185.94 | 83 |
| GSM780728 | Trastuzumab and Pertuzumab treated after 4 days (TP1_2) | 189.329 | 83 |
| GSM780729 | Trastuzumab and Pertuzumab treated after 4 days (TP2_2) | 206.851 | 84 |